This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Targovax Oy. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Anniina Koski: Innovator in Cancer Therapy
Introduction
Anniina Koski is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of cancer therapy through her innovative work on adenoviral vectors. Her research focuses on developing safer and more effective treatments for cancer patients.
Latest Patents
Anniina Koski holds 1 patent for her invention titled "Recombinant serotype 5 (Ad5) adenoviral vectors." This invention relates to oncolytic adenovirus vectors and their applications in cancer therapy. The adenoviral vectors developed by Koski exhibit superior safety properties and demonstrate effective therapeutic activity. Additionally, she has disclosed a production method for these inventive adenoviruses, which are particularly useful in cancer treatment.
Career Highlights
Anniina Koski is currently associated with Targovax Oy, a company dedicated to developing innovative cancer therapies. Her work at Targovax Oy has positioned her as a key player in the advancement of oncolytic virus therapies.
Collaborations
Throughout her career, Anniina has collaborated with notable colleagues, including Tuuli Ranki and Akseli Hemminki. These collaborations have further enriched her research and contributed to the development of effective cancer therapies.
Conclusion
Anniina Koski's innovative work in the field of cancer therapy exemplifies her commitment to improving patient outcomes through advanced medical technologies. Her contributions to adenoviral vector research are paving the way for safer and more effective cancer treatments.